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Immobilized chemoattractant peptides mediate adhesion and distinct calcium-dependent cell signaling in human neutrophils
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Introduction
Chemotaxis plays a major role in inflammation, i.e. during recruitment of circulating leukocytes from the blood vessel lumen to the site of damaged tissue or infection. [1] [2] [3] It is thus desirable to understand and eventually control this intricately regulated directed cellular migration towards a gradient of stimuli in a number of diseases with an inflammatory component, for example rheumatoid diseases, cancer, and atheriosclerosis, and also in wound healing. Chemoattractants comprise a multitude of stimuli that range from endogenous cytokines (chemokines), complement activation products and lipid metabolites, to exogenous molecules like the bacterial formyl-methionyl-leucyl-phenylalanine (fMLF or fMLP) peptide family. Locomotion is mediated via activation of serpentine (seven transmembrane, 7 TM) receptors, thereby triggering a phospholipase C-dependent transient cytosolic calcium mobilization and activation of protein kinase C. The bactericidal neutrophilic granulocytes (neutrophils) are highly motile upon fMLF stimulation, which triggers both chemotaxis and calcium-dependent oxidative metabolism. [4] [5] [6] [7] Neutrophils express at least two G-protein receptors to fMLF, a high affinity formyl peptide receptor (FPR), and a low affinity formyl peptide receptor-like 1 (FPRL1). 8, 9 The receptors are normally evenly distributed in the plasma membrane, but upon stimulation two functional receptor subpopulations accumulate in regions involved in motility 10, 11 Upon arrival to the tissue, these cells aim at eliminating pathogens by engulfment (phagocytosis) and/or by release of stored cytotoxic substances, e.g. hydrolytic enzymes and reactive oxygen species generated via the NADPH oxidase.
Despite that several experimental models to study leukocyte chemotaxis have been around for decades, as recently reviewed comprehensively, 12, 13 a detailed understanding of chemoattractant receptor signaling and its complex dynamic interplay with cell adhesion molecules (selectins, integrins and the immunoglobulin superfamily) and other immunological receptors is not available. Established methods employ measurement of a leading front of a population of cells and include two-compartment filter assays, 14, 15 migration under cell-impermeable agarose, 16 , 17 cell-permeable gels of structural extracellular matrix proteins, 18 and different type of microscopy chambers. 19, 20 Some experimental platforms are optimized for combination with cellular imaging and individual cell tracking in 3D. 12, 13, 21, 22 Still some limitations remain, e.g. compatibility issues and lack of a detailed spatial and temporal control of chemoattractant distribution, or failure to provide a well-defined mixture of different stimuli. Furthermore, stimulation of either FPR or FPRL-1 triggers functionally similar oxidative activation patterns in neutrophils, and assaying the ratio between the respiratory burst triggered by specific agonists could be a promising tool in several applications. 23 Chemoattractant peptides are often anticipated to exert their actions only as soluble molecules, but they do also attach to the substratum. This was early on observed in vitro for fMLF in the under-agarose chemotaxis system displaying a gradient of surface-bound chemoattractants, 17 and, chemokines can be localized by specific and non-specific binding to glycosaminoglycans and thus proteoglycans on the surfaces of cells or in the extracellular matrix. [24] [25] [26] [27] Hence it is desirable to be able to attach an active peptide or combinations of peptides to surfaces, thereby facilitating gradient design and enabling re-stimulation of the cells with other agonists and combination with established and emerging techniques. Immobilization of chemoattractants on supporting substrates offer a precise and controlled alternative to humoral stimulation, and could enhance the current understanding of inflammation and tissue engineering. This is also applicable to biosensor design where cells could be recruited to a specific site.
Related but based on different concepts are provided by the integrin receptor RGD adhesion motifs at interfaces to promote firm cell-surface interactions in biomaterials, 28 the careful simultaneous design of both surface chemistry and topology of to control mammalian cell behavior at imaging-compatible interfaces, 29, 30 and the microparticle-based slow-release models for chemoattractants. 31 We have aimed at an immobilization strategy allowing imaging of de novo synthesized potent fMLF receptor peptide agonist analogues; N-formyl-Met-Leu-Phe and N-formyl-Tyr-Nle-Phe-Leu-Nle modified with a spacer tail GlyGly-Gly and a C-terminal cysteine that permit site-specific attachment via thiol coupling to gold or a maleimide-containing self-assembled monolayer (SAM). A N-terminal formylated Gly-Gly-Gly-Cys peptide was used as a reference peptide. The use of a maleimide-containing SAM 32, 33 ( Fig. 1 ) offers molecular flexibility, adjustable peptide surface concentration, controlled peptide-surface vertical distance, and most importantly, efficient shielding of cells from directly interacting with the supporting gold substrate. The importance of such a barrier layer is clearly demonstrated, and suggests that the two-step maleimide-peptide immobilization process used offers a convenient route for the generation of a biologically active fMLF receptor peptide surface compatible with cellular imaging.
Results and Discussion
Biological activity of peptides: The two receptor agonist motifs were designed to be potent activators of the neutrophil chemotaxis, cytosolic calcium and the respiratory burst. However, in order to ascertain that their biological activity maintained after addition of the Gly-Gly-Gly-Cys sequence, submicromolar concentrations of the synthesized peptide analogues were initially screened for neutrophil NADPH oxidase activation capacity ( Fig. 2A) . Both agonist analogues yielded rapid generation of reactive oxygen species in a similar fashion as the original agonists (lacking the Gly-Gly-Gly-Cys motif). The short formylated control peptide showed no apparent sign of triggering neutrophil bactericidal activity.
Ratio imaging:
Chemoattractants trigger calcium transients, and fluorescence ratio imaging 34, 35 was thus chosen to study fMLF activation of neutrophils on substrates. The peptide immobilization and characterization protocol required a gold support and hence it was necessary to use gold films also during cell activation experiments. Unfortunately, direct application of single excitation wavelength fluorescence microscopy in live cellular imaging on non-transparent reflective metal films introduces several challenges.
These include primarily general distortion and rapid decay in emission because of extensive light reflections, particulary in the absence of anti-fading agents, but there are also difficulties in confirming the true origin of emission. By fabricating semi-transparent cover slips it was possible to use simultaneous bright-field imaging to ascertain fluorescence emanating from the cytosol of individual cells. When using fura-2, a fluorophore that display opposite optical responses at two different excitation wavelengths, it is possible to work with the ratio and thereby obtain a more reliable stable baseline and a high dynamic range, relatively independent on various confounders e.g. morphology of the cells and noise. Accordingly, soluble fMLF receptor agonists were found to trigger cytoslic calcium transients in individual neutrophils when ratio imaging was performed through the semi-transparent gold. This is clearly evident in Fig. 2B where we show typical calcium transients in five different cells. These signals precede the respiratory burst seen in Fig. 2A .
Thickness and wettability of peptide layers and SAMs:
The control and agonist peptides were sitespecifically immobilized directly to gold by employing thiol coupling via the C-terminal cysteine, resulting in ellipsometric layer thicknesses between ~12-20Å and contact angles of 12-72 (Supporting Information S1). Unfortunately, this immobilization protocol yielded layers of the control peptide and the two agonist analogues for which the subsequent neutrophil responses were similar to those obtained for bare gold (data not shown). These observations clearly suggested that the neutrophils can sense the underlying substrate, and that the vertical distance between the surface and the peptides has to be increased by forming a dense barrier SAM on the gold surface. The thicknesses of such barrier SAMs composed of hydroxyl-and maleimide-terminated EG 4 disulphides 32, 33 were found to be ~14 and ~19Å, depending on the relative composition of 10% or 100% of maleimide-termination, respectively. Subsequent formation of peptide layers on top of the barrier SAMs revealed incremental thickness changes Δd of about 1-2Å and 5-15Å for surfaces with 10% and 100% maleimide-termination, respectively ( Table 1 ). The increases in contact angle after peptide agonist immobilization were in concert with the ellipsometric thicknesses and the contact angles obtained for the pure peptide layers. Thus, the N-formyl-Gly-Gly-Gly-Cys is a hydrophilic peptide, whereas both agonists tend to be more hydrophobic, the long N-formyl-Tyr-Nle-Phe-Leu-Nle-Gly-GlyGly-Cys in particular.
Infrared spectroscopy:
The isotropic IR transmission spectra of the synthesized peptides dispersed in KBr and pressed into pellets are shown in Fig. 3 . Considerable efforts have been devoted to studies aiming at finding correlations between the Amide I peak position and the secondary structure of the polypeptide backbone, and as a rule of thumb, polypeptides exhibiting the anti-parallel -sheet conformation absorbs in the range ~1675-1695 and ~1625-1640 cm -1 , the -helical ~1648-1660 cm -1 , the unordered state ~1646-1658 cm -1 , respectively. 36 For the short control peptide at least three different amide I peaks could be seen in the finger print region of the isotropic IR spectrum (Fig. 3A) . The Amide I peak frequencies range from 1634 to 1689 cm -1 with a dominating feature at 1634 cm -1 , indicating, at first glance and according to the guide lines above, that the peptide backbone adopts the β-sheet conformation. For the long agonist ( Fig.   3B ) a single peak was seen at 1650 cm -1 , whereas two amide I peaks were found in the range 1636-1654 cm -1 for the short agonist (Fig. 3C ). Although the peptides displayed Amide I peaks in the regions expected for α-helical and β-sheet conformations, it is doubtful whether they can be attributed to extended segments of such conformations considering the short length of the peptides. It is more likely that the polypeptide backbones consist of significant amounts of unordered segments, an assumption supported by the ChouFasman rules. 37, 38 We thus conclude that the infrared spectra of the peptides display a varying distribution of Amide I peaks, which most likely reflects the complicated interplay between intra-and interchain interactions occurring in the crystalline state. The amide II peak, which is less sensitive to polypeptide chain conformation, could be found at about 1546 cm -1 for the control and the shorter agonist peptides, respectively, but had shifted to 1517-1536 cm -1 (two peaks) for the long agonist. The 1517 cm -1 peak is attributed to the tyrosine residue, which is present only in that spectrum of long agonist (Fig. 3B) .
Moreover, the Amide III peak appeared as a broad feature near 1235 cm -1 in all peptide spectra, and CH 2, 3 bending modes from the amino acid side chains in the range 1370-1470 cm -1 . Peaks were also seen near 3295 cm -1 and in the range 2850-3000 cm -1 and they are assigned to NH stretching (Amide A) and CH 2, 3 stretching modes, respectively (not shown).
The fine details seen in the RA spectra of the various peptide layers are dependent on the procedure used to obtain representative spectra. For instance, the spectrum in Fig. 4A is the sum of the spectra of the maleimide SAM and the attached peptide overlayer, here represented by the long agonist. In order to obtain a spectrum of the peptide overlayer (C) it is necessary to subtract the maleimide SAM spectrum in Fig 4B from that in (Table 1 and Supporting Information S1). The position of the Amide I peaks were all shifted to higher frequencies in the RA spectra, as compared to the KBr spectra (see remain in the observed microscopy view for more than a few min. Despite this, it was possible to record a short sequence on this control matrix where neutrophils were clearly shown to retain full calcium mobilization potential in response to a humoral stimulation with fMLF (Fig. 7C) . Furthermore, immediately upon soluble fMLF-stimulation bright-field imaging revealed that the neutrophils now tryed to extend
protrusions, yet remaining unsuccessful in acquiring a firm adhesion to the control substratum (not shown).
Moreover, presence of fMLF in solution prior to adhesion of cells inhibited or delayed neutrophil spreading on the agonist substratum (Supporting Information S3). This supports the suggestion of FPR-mediated activation at the agonist surface and, importantly, a very low non-specific activation by the shielding maleimide-SAM. This is an important observation, since in line with previous work in our laboratory, 43 the ratio imaging also showed that bare gold surfaces instead form a rather hostile environment for blood cells such as neutrophils, and that fMLF-peptide analogues being immobilized without the SAMs failed in triggering apparent calcium activation (not shown). The latter was most likely because of the non-specific nature of the pre-activation mediated by bare gold and surface contact per se, probably engaging a multitude of cell adhesion receptors (including the integrins).
Fixation of cells subsequent to ratio imaging sessions, followed by Alexa488-phallacidin staining and fluorescence microscopy evaluation of the filamentous actin cytoskeleton confirmed the real-time brightfield image observations. The chemoattractant peptide SAM (Fig. 8A ) rapidly recruited neutrophils to near confluency, with good spreading, supporting a good bioavailability of the chemoattractant peptide with an intact cell recruiting capacity. In this regard, it is possible to consider fMLF-and non-stimulated neutrophils almost as two separate cell populations. Depending on the dose, neutrophil interaction with the chemoattractant will affect not only FPR/FPRL-1 binding and receptor distribrution, but it will also regulate the expression of a number of true cell adhesion receptors, e.g. integrins, with putative specific and non-specific binding capacities to a multitude of biological and artificial surfaces. In order to assess whether the adhesion at the agonist surface was mainly a FPR-mediated event, neutrophil FPRL-1 and a major adhesion integrin complement receptor type 3 (CR3, same as CD18/CD11b) were blocked prior to surface interactions via neutrophil pre-incubation with relatively high doses of FPRL-1 antagonist peptide WRWWWW or anti-CD11b monoclonal antibody LM2/1.6.11, respectively (Supporting Information S2).
For the short duration (10-15 min) of cell-surface interaction in scope in the present study, these measures did not affect neutrophil adhesion, spreading, or filamentous actin distribution. In line with this, LM2/1.6.11 showed no effect on the calcium response triggered by the long agonist surface (not shown).
On the contrary, the cell count was indeed lower on the formylated control peptide surface (Fig. 8B) , and morphology similar to what could be expected for any surface coated with a low-adhesive motif. Although, the local coverage in the selected area shown in Fig. 8B is higher than the average microscope view, the cells maintained a spherical morphology typical for non-activated neutrophils. Taken together, our observations clearly demonstrate that a spacer layer is an absolute pre-requisite to avoid interfering interactions with the gold substrate. The OEG portion of the spacer also provides a biocompatibile environment for the interacting cells.
Neutrophil interactions with immobilized chemoattractants during inflammation:
Facing the complexity of neutrophil recruitment, the application potential of designed chemoattractant surfaces is vast. In summary, the proposed immobilization protocol of fMLF receptor agonists yielded SAMs that trigger chemoattractant stimulation of human neutrophil granulocytes. Future experiments will assess the impact of this approach, using different ligand-receptor combinations, and involve peptides in mixed layers, gradients and/or patterns, making more extensive studies on cell migration feasible.
Conclusions
We have demonstrated how two fMLF receptor peptide agonists may be designed to suit thiol coupling to semitransparent gold cover slips with retained ability to trigger neutrophil activation. By immobilization of the peptides to SAMs of maleimide-and hydroxyl terminated and OEG containing alkyldisulphides on gold, it is possible prevent interfering interactions with the gold substrate and obtain fully functional peptide layers. The agonist triggers appropriate neutrophil activation after immobilization, as evidenced by calcium-dependent signaling and rapid association and spreading on the substrate. Thus, we believe that the employed approach can be further developed into an experimental platform for studies of cell adhesion and activation.
Experimental Section
Peptides: Two analogues (Fig. 1A-B ) to known fMLF receptor agonists, as well as one formylated control peptide (Fig. 1C) , were synthesized on 0.1-0.2 mmol scales using standard fluorenylmethoxycarbonyl Sciences, Dublin, Ireland), whereas the long agonist was purified using a gradient of aqueous ACN from 80 to 50% in 20 min and from 50% to 30% in further 25 min and the short agonist using a gradient from 80%
to 60% in 30 min. The purified peptides were stored in a lyophilized state. When used, the peptides were dissolved with the assumption that 30% of the total mass was water. During synthesis the products were continuously controlled by MALDI-TOF mass spectrometry (Voyager-DE STR Biospectrometry Workstation, Applied Biosystems). For some control experiments, commercially FPR agonist fMLF (Sigma-Aldrich) and FPLR1 antagonist WRWWWW (Calbiochem, La Jolla, CA) were used. The latter was used at 1 µM, a dose reported to display no non-specific activation in neutrophils. 52 In addition, the monoclonal azide free anti-CD11b antibody LM2/1.6.11 (kind gift from Dr. Carl G. Gahmberg, University of Helsinki, Finland) was used to block adhesion and activation mediated by integrin CR3 (complement receptor type 3).
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Inorganic supports: No. 1 Menzel-Gläser (Braunschweig, Germany) cover slips (30 x 0.17 mm) were evaporated with 10Å titanium and 120Å gold 30 for all microscopy studies. The coated slips were semitransparent (25-40% transmission) in the range 340-580 nm and thus compatible with examination using an inverted fluorescence microscope. Characterization of peptide immobilization using ellipsometry, contact angle goniometry and infrared reflection absorption spectroscopy (IRAS) was performed on standard, cleaned silicon (100) wafers (Wacker-Chemie GmbH, München, Germany) coated with a 25Å titanium adhesion layer and, subsequently, with 2000Å gold. Details on the substrate cleaning prior to deposition and the gold deposition can be found elsewhere, 54 with the exception that the evaporation rate for gold on the cover slips was reduced from 10 to 5Å/s. Gold substrates were cleaned in a mixture of water, 30% hydrogen peroxide and 25% ammonia (5:1:1) for 5 min at 80C, and rinsed extensively in water prior to incubation.
Peptide immobilizations:
SAMs of hydroxyl-and maleimide terminated EG 4 disulphides ( Fig. 1D-E) were used as linkers and spacers in the immobilization process, to offer extended flexibility, increasing the vertical distance, and shielding of the cells from the bare substrate. Cleaned substrates were incubated for 24h in 50 M solutions of maleimide-and hydroxyl-terminated EG 4 disulphides in ethanol (Kemetyl AB, Haninge, Sweden), with maleimide-termination ranging from 10% to 100%. Peptide solutions (50 M)
were prepared in water (control peptide, Fig. 2A 100 nM fMLF present in solution
